Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Thermo Fisher nets $2.46bn via FOPO; largest for life sciences company

Executive Summary

Thermo Fisher Scientific Inc. netted $2.46bn through the follow-on public offering of 29.6mm common shares (including the overallotment) at $85.50. The proceeds will help fund its proposed $15.2bn acquisition of Life Technologies Corp., which Thermo Fisher announced in April. The transaction is the third-largest medical company FOPO to date behind Mylan (2009) and Roche (2006)--each grossed about $2.9bn--but the biggest for a life sciences/research firm.
Deal Industry
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
  • Laboratory Testing Services
  • Research, Analytical Equipment & Supplies
    • PCR & Amplification Tools
Deal Status
  • Final
Deal Type
  • Financing
    • FOPO

Related Companies